Titers of serum antibody and cell-mediated immunity (CMI) to Bordetella pertussis antigens were assessed in a cohort of Italian military school students for whom the coverage of pertussis vaccination was low. The overall prevalence of IgG antibody above the minimum level of detection (MLD) was 71.6% for pertussis toxin (PT), 81% for pertactin (PRN), and 99% for filamentous hemagglutinin (FHA). Levels of IgA antibody to PT above the MLD were detected in 15.9% of the study participants. CMI to FHA, PRN, and PT was positive in 97%, 100%, and 82% of tested individuals, respectively. Only 9.7% of the participants had neither antibody nor CMI specific to B. pertussis antigens. In the 5-month clinical, microbiological, and serological follow-up conducted during a high-risk period of pertussis, no cases of pertussis were detected. These data, in particular CMI, demonstrate that most Italian young adults are specifically primed against B. pertussis, which should be taken into consideration when future policy on pertussis vaccination is being made in Italy.
Although pertussis is generally considered a childhood disis mostly confined to the very young population, with the highest attack rate at 5 years of age [13] . However, pertussis in ease [1] , an increased incidence among adolescents and adults has been recently reported in the United States [2] . Recent adults is often characterized by a mild clinical presentation and can go unrecognized. studies suggest that adults may represent a natural reservoir of Bordetella pertussis, thus contributing to its transmission even
The main objective of this study was to obtain evidence of exposure to B. pertussis, as inferred from immunologic markers in a population for whom the coverage of childhood vaccination is high [3 -9] . Moreover, a recent study carried out in Germany assessed in a closed community of healthy young male adults belonging to birth cohorts for whom the vaccination coverage [10] indicated that B. pertussis infections are also common in adults who were infected with pertussis in childhood.
was low. Cell-mediated immunity (CMI) was also included among the immunologic markers studied. In addition, the secSince the 1960s, when the whole-cell pertussis vaccine was first made available in Italy, pertussis immunization of infants ondary objective of the study was to conduct an intensive surveillance for pertussis in the study population over a 5-has only been voluntary (while immunization with diphtheria and tetanus toxoids and live oral poliovirus vaccine has been month period during a time of high risk for pertussis. mandatory) and is not actively offered in all Italian regions. The recommended ages at which the pertussis vaccine is administered are 3, 5, and 7 months, with booster doses at 2 and 6 Methods years. Vaccination coverage for pertussis has been unsatisfactory in most of the birth cohorts over the last 25 years, despite Study Design the availability of the whole-cell vaccine [11, 12] . Data from national immunization surveys show that pertussis vaccination In Italy, pertussis follows a cyclic pattern; epidemics take coverage declined during the 1970s, ranging from 16% for the place every 3 -5 years, and most cases occur in spring and 1974 birth cohort to 11% for the 1981 birth cohort. Coverage early summer [14] . The study, which began in March 1995, remained low in the early 1980s and increased to an estimated included an initial cross-sectional investigation to determine 40% in 1991. According to pertussis notifications, the disease the prevalence of immunologic markers of exposure to B. pertussis and of factors potentially related to pertussis. A 5-month follow-up for clinical pertussis was subsequently carried out
Study Population
ELISA units (EUs) were computed from the absorbance measured through a standardized software (Unitcalc [1992 verThe study population included healthy males attending milision]; Biosys inova, Stockholm) providing results according to tary boarding schools in the year 1994 to 1995 in the towns both the original parallel line method and the reference line of Viterbo (central Italy) and Caserta (southern Italy). The age method. The two methods provided comparable results at low of the students ranged from 17 to 25 years, and they originated titers, but the agreement was lower at higher antibody concenfrom different parts of Italy. For admission to the school, stutrations. On the basis of a recent international evaluation [16] , dents must pass a medical and laboratory examination for fitthe reference line method was chosen to determine EU. ness. In 1994, 450 students were enrolled in the school in
The minimal level of detection (MLD) was set at 2 EU/mL Caserta, and 250, in the school in Viterbo. In March 1995, all for IgG antibodies to PT and FHA, at 3 EU/mL for IgG antistudents in the two schools were invited to participate in the body to PRN, and at 10 EU/mL for IgA antibody to PT [17] . present study. Participation was voluntary, and written inEvaluation of intraassay variability was performed by computformed consent was required.
ing the daily coefficient of variation of positive control sera, which did not exceed 23%. A serological assay was considered positive when the antibody titer exceeded the MLD defined for
Cross-sectional Study each determination. Seroprevalence of humoral markers was At the beginning of the study, each participant answered a defined as the proportion of individuals with a specific antibody questionnaire that included basic demographic data, history of titer above the MLD. pertussis vaccination and disease, history of cough episodes in the previous 12 months, and smoking habits. A sample of
Assessment of CMI
venous blood was taken to assess the presence of antibodies to B. pertussis. CMI to B. pertussis antigens was also assessed
Another sample of venous blood (at least 5 mL) was colfor a subsample of 62 individuals (15% of the total) who were lected from 62 participants for CMI assessment by the lymphorandomly chosen from the participants.
cyte proliferation assay of peripheral blood mononuclear cells (PBMCs), as described elsewhere [18, 19] . PBMC proliferations induced by mitogens (phytohemagglutinin and IL-2) were
Follow-up Study
used as the positive controls. CMI to B. pertussis antigens was considered to be positive when the difference between the In the 5 months after the cross-sectional study, active surveilantigen-stimulated PBMC culture and the unstimulated control lance of cough episodes was performed by a nurse who was culture was at least 3 1 10 3 counts per minute (cpm). Data are based at the boarding school and was responsible for detecting reported as the stimulation index (SI), that is, the ratio of cpm and reporting cough episodes. For each episode lasting at least of the stimulated culture to the cpm of the unstimulated culture. 7 days, a nasopharyngeal aspirate for B. pertussis culture was
Since the cpm of unstimulated PBMC cultures were always taken. A convalescent-phase serum sample was collected 6 -£1,000, the above-mentioned definition of positivity corre-8 weeks after the onset of cough, according to established sponds to an SI of §4.0. procedures [15] , to detect if the antibody titer increased sig-CMI to common recall antigens, such as tetanus toxoid and nificantly from that measured in the initial cross-sectional mannoprotein from Candida albicans, were also included as study.
controls. Purified B. pertussis antigens and tetanus toxoid were provided by Chiron-Biocine (Sienna, Italy); mannoprotein was Laboratory Studies an in-house preparation [18] .
Serology Nasopharyngeal Aspirates
Serum samples collected in the cross-sectional study were stored at 020ЊC. All ELISAs were performed at the DepartNasopharyngeal aspirates -collected by means of an 8 French De Lee suction catheter (Sherwood Medical, St. ment of Hygiene and Microbiology in the Microbiology Unit of the University of Palermo. The samples were tested for B.
Louis) -from individuals with a cough lasting at least 7 days were cultured on charcoal agar containing 10% defibrinated pertussis antigens by using a reference serum calibrated against reference serum samples provided by the U.S. IgG antibody to PT, which was similar to the overall prevalence in the study (259 of 450 students in Caserta and 157 of 250 among the entire study population. Of the 17 individuals who in Viterbo). Overall, 416 individuals were enrolled in the study. The mean age of the participants was 21.7 years (median, 22 years; range, 17 -25 years), which was similar to the age distribution for the entire school population. The number of household members in the students' families ranged from two to 10 (mean { SD, 4.36 { 1.14; mode, 4).
The place of birth was northern Italy for 8.1% of the participants, central Italy for 26.3%, and southern Italy for 55.1%; 2% of the participants were born abroad, and 9.5% did not provide this information. Only 4.1% of the participants reported vaccination against pertussis in childhood; 29.3% reported that they had not been vaccinated, and 66.7% did not provide this information. A history of pertussis was reported by 32.1% of the participants. No documentation of history of vaccination or infection was available. Smoking was reported by 21.1% of the participants. History of cough in the previous year was reported by 65% of the participants, and for 12%, the cough duration was ú7 days. reported vaccination against pertussis, 70.6% had a titer of IgG of antibodies to each antigen did not correlate with the magnitude of the CMI. antibody to PT above the MLD (table 2) .
Surveillance of Cough Episodes CMI
Ten cough episodes lasting ú7 seven days were detected CMI to PT, FHA, and PRN was positive in 51 (82%), 60 during the 5-month study period. The average duration was 10 (97%), and 62 (100%) of 62 participants, respectively. The SI days per episode, and the cough, mainly productive and without for individuals with responses was lower after stimulation with spasms, required antibiotic treatment in two cases. None of PT than after that with the other antigens tested. The prevathese episodes were laboratory-confirmed pertussis. In all 10 lence of CMI to FHA and PRN was similar to that of CMI to episodes, microbiological culture of the nasopharyngeal aspitetanus toxoid (as expected, considering that all participants rate was negative. No significant increase in antibody titers receive a booster dose of tetanus toxoid) as well as that of was detected in any of the convalescent-phase serum samples CMI to mannoprotein from C. albicans, a commensal microortaken 6 to 8 weeks after the onset of cough. Pre-and postillness ganism to which most humans are naturally sensitized (table GMTs of antibodies to FHA and PT for participants with cough 3). Of the 51 individuals with CMI to PT, 35 also had titers were slightly lower than the corresponding values observed for of IgG antibody to PT above the MLD. The remaining particithe entire study group in the cross-sectional part of the study. pants had antibodies to FHA and PRN. Of the 11 participants without CMI to PT, five had IgG antibody to PT. The GMTs
Discussion
The resurgence of pertussis in countries with high vaccina- kinson [20] showed that the efficacy of the whole-cell pertussis The present study provides further information on the prevacally identified pertussis in Italian adults is supported by data from the official notification system and is suggested by the lence of antibodies to PT and other antigens of B. pertussis in adults as well as CMI to these antigens. CMI has been recently follow-up performed in the present study, although the length of observation was limited because of feasibility constraints shown to persist longer than titers of antibody to B. pertussis antigens in vaccinated children [18] , suggesting that CMI is a in the closed community. More precise evaluation of the incidence of pertussis will require extensive active surveillance more stable marker than humoral response of a state of immune priming against B. pertussis. In our study, titers of circulating of a larger population. Whether the high frequency of this priming justifies a booster dose of vaccine is currently being antibodies to PT above the MLD were found in 71.6% of the young adults. Of the 62 individuals included in the CMI debated; nonetheless, in Italy, priority must still be given to increasing pertussis vaccination coverage among infants and assessment, 82% had proliferative cellular response to PT, of whom 68.6% had antibodies above the MLD to PT; only 9.7% thus to reducing the occurrence of most of the preventable cases. were found to be negative for both humoral and cellular immunity. Thus, a total of 90.3% of the participants were found to be carriers of a marker of previous exposure to B. pertussis,
